Shanghai OPM Biosciences Future Growth
Future criteria checks 5/6
Shanghai OPM Biosciences is forecast to grow earnings and revenue by 48.6% and 35.1% per annum respectively. EPS is expected to grow by 48.6% per annum. Return on equity is forecast to be 7.1% in 3 years.
Key information
48.6%
Earnings growth rate
48.6%
EPS growth rate
Biotechs earnings growth | 34.2% |
Revenue growth rate | 35.1% |
Future return on equity | 7.1% |
Analyst coverage | Low |
Last updated | 05 Jun 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 686 | 219 | 66 | 223 | 3 |
12/31/2025 | 500 | 150 | -3 | 137 | 3 |
12/31/2024 | 348 | 89 | 42 | 151 | 3 |
3/31/2024 | 255 | 49 | -31 | 59 | N/A |
12/31/2023 | 243 | 54 | -20 | 58 | N/A |
9/30/2023 | 243 | 65 | -78 | 52 | N/A |
6/30/2023 | 269 | 90 | -39 | 103 | N/A |
3/31/2023 | 290 | 104 | -28 | 114 | N/A |
12/31/2022 | 294 | 105 | -35 | 112 | N/A |
9/30/2022 | 285 | 97 | -2 | 134 | N/A |
6/30/2022 | 277 | 95 | -5 | 111 | N/A |
3/31/2022 | 244 | 76 | -10 | 105 | N/A |
12/31/2021 | 213 | 60 | 9 | 115 | N/A |
12/31/2020 | 125 | 12 | -33 | 3 | N/A |
12/31/2019 | 59 | -12 | -3 | 17 | N/A |
12/31/2018 | 34 | -42 | -55 | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688293's forecast earnings growth (48.6% per year) is above the savings rate (2.9%).
Earnings vs Market: 688293's earnings (48.6% per year) are forecast to grow faster than the CN market (22.2% per year).
High Growth Earnings: 688293's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688293's revenue (35.1% per year) is forecast to grow faster than the CN market (13.6% per year).
High Growth Revenue: 688293's revenue (35.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688293's Return on Equity is forecast to be low in 3 years time (7.1%).